Neumora Therapeutics
phase efficacy population patient demographics and characteristics similar across treatment groups | Neumora Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
September 2023
Slide
31 of 32
Related slides by other companies
BioAtla
Investor Presentation
January 2024
phase cab demographics tumor types | BioAtla
BioNTech
Results
November 2020
phase a safety profile | BioNTech
Adagio Therapeutics
Investor Presentation
June 2023
even in primarily populations vaccine effectiveness has waned in the face of viral evolution | Adagio Therapeutics
Ocuphire Pharma
Investor Day
January 2022
safety summary from phase and phase studies way | Ocuphire Pharma
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io